Re: Digest Number 971

[Guest guest]

In a message dated 1/26/00 12:06:30 PM Eastern Standard Time,

lyme-aidonelist writes:

<< Message: 9

Date: Wed, 26 Jan 2000 08:23:54 -0500

From: " J & M McCoy " <mlmccoy@...>

Subject: Re: Fibroid tumors / lyme

>>

Hi Marta &

I had to have a hysterectomy last year because of excessive uterine

bleeding ( every two weeks for a 1 & 1/2 yrs.) They tried everything to stop

it, but nothing worked. It all started after the birth of my third child.

After the birth of my 2nd child I had problem w/bleeding, too, plus severe

cervical dysplasia. After two surgeries things were resolved that time. This

past time before the hyst, they couldn't find any reason for the bleeding,

but after I was dx with Lyme in late May of 99 I read that Lyme can cause

abnormal uterine bleeding. Since it can cause problems with bleeding I don't

know why it couldn't cause other " female " problems. Fibroids, cysts and the

like are believed to be caused by viruses that cause a change in our hormone

levels, which inturn can cause a whole slew of problems.....even cancer.

Marta, I hope that you won't have to have a hyst., but I personally am so

glad that I had it.....No more feminine products (at least until my daughters

start), no more cramps, etc.... I kept my overies, so I don't even have to

deal with HRT's ( depending on your age, you may not have to have your

overies out either, but if you are close to menopause they sometimes

recommend it).

Sorry guys about all the details....It could have been worse...lol !!!

Your Lyme Friend,

[Guest guest]

In a message dated 1/26/00 12:06:30 PM Eastern Standard Time,

lyme-aidonelist writes:

<< The tick is an Amblyoma

(sp?) genus tick called the African Tortoise Tick.

>>

Boy Jim, that sure was a scarry report. I hope they fight like hell in

Florida to regulate things. Thanks for sharing this with us.

Your Lyme Friend,

[Guest guest]

Greetings on this Memorial Day weekend from the Anthrax Vaccine Network.

Our May newsletter is going out in the mail today and tomorrow. If you are

not a member of the Network and would like a newsletter, please send your

information to contact@.... We are here to help ill troops

meet each other, to serve as a source of referral to those needing medical

and legal help, and to work together, as a united front, to educate the

public about what is going and and take grass-roots political action. There

is no charge for anyone ill from the vaccine, or for those who have refused

the vaccine and been punished. Our intent is develop such a swell of united

public opinion that we cannot be ignored by the Pentagon or anyone else --

and our numbers are growing steadily. Please contact us if you would like

more information. Meantime, to all our troops and vets, and to those who

have paid the ultimate price, our verse - and mission - is repeated here:

We will not desert you.

You, who have donned the uniform of your country

and pledged your life to defend us,

We pledge to defend you with our honor, our work, the

sweat of our brows

Until you are no longer a medical experiment;

Until your pain is treated, and treated correctly;

Until your voice is heard and you are no longer ignored;

Until your sacrifices are recognized and you no longer

have to defend yourself against your own government.

You do us honor in the face of those who would shame you.

We will walk with you. We will not desert you.

Good Memorial Day, everyone -

Kathy

Digest Number 971

> Our Anthrax information web site: http://www.dallasnw.quik.com/cyberella/

> PETITION TO OVERTURN/REPEAL FERES DOCTRINE http://www.i-charity.net/ptn/80

> To visit Dr. Meryl Nass's web site, go to: http://www.anthraxvaccine.org

> Also visit: http://www.MajorBates.com/ and http://www.enter.net/~jfsorg/

> http://www.jamesmadisonproject.org/importantlinks.html and

http://www.aboutanthrax.org

> Anthrax Vaccine Network proposal http://www.anthraxvaccine.net

> Sgt. Larson's story

http://stripes.com/servlet/News/ViewArticle?articleId=100036895

>

http://www.house.gov/reform/hearings/healthcare/00.10.03/accountability.doc

> Contact list owner: Gretchen Whitney at: anna_nim@...

>

[Guest guest]

,

Hang your head HIGH! Those of us living and dealing with the after

affects would gladly have done what you have done if we knew back in 98 what

we know now. I think they call what you did " COURAGE " ! It's a shame that

others do not have the GUTS that really know the truth to step forward and

be COUNTED! Your actions are a Sterling example for others to follow. My

blessings to you and yours for standing up for the sick Troops! You did " THE

RIGHT THING " !

V/R

Bob and family

Digest Number 971

Our Anthrax information web site: http://www.dallasnw.quik.com/cyberella/

PETITION TO OVERTURN/REPEAL FERES DOCTRINE http://www.i-charity.net/ptn/80

To visit Dr. Meryl Nass's web site, go to: http://www.anthraxvaccine.org

Also visit: http://www.MajorBates.com/ and http://www.enter.net/~jfsorg/

http://www.jamesmadisonproject.org/importantlinks.html and

http://www.aboutanthrax.org

Anthrax Vaccine Network proposal http://www.anthraxvaccine.net

Sgt. Larson's story

http://stripes.com/servlet/News/ViewArticle?articleId=100036895

http://www.house.gov/reform/hearings/healthcare/00.10.03/accountability.doc

Contact list owner: Gretchen Whitney at: anna_nim@...

[Guest guest]

I want to say Thank You to all the nice Welcomes !

After reading, I see that many of you really have some

difficult situations you are encountering, and the

love for your Children has given you great strength

and courage to look for the best treatments and

solutions to problems.

I have to say that I feel comforted that there is

this group, I don't feel so alone I really feel in

awe, and chagrined that I have been worrying about

such small problems that my daughter has exhibited in

comparision to some of the very difficult things I

have read about.

I certainly expect to learn some stratiges and hope

that at some point I can be a help to others.

Warm Regards

Cat Mom to Alysha 12/05/76

__________________________________________________

[Guest guest]

Hello everyone,

I posted about a month ago about my desire to try CP

(I am a M & P crafter) Many members gave me good solid

advice. My most concern was about my fear of using

lye. Well last night - after a few deep breaths, I

suited up for the task - I wore safety goggles, a mask

to cover my face and nose, a baseball cap to protect

my forhead, hair, a towel to protect my neck, a

sweatshirt, latex gloves, sweatpants, socks and

sneakers. I made sure the distilled water was very

very cold (a thin layer of ice on top) I began to

pour the lye beads into the water (I did this in my

kitchen by the window, which was open) I didn't get

any boiling, nor did I see any puffs of fumes, smoke

or anything. I stirred well, then waited about a half

hour, during this time, I prepared my oils - Oh by the

way, I was making Vanilla Almond Oatmeal soap. The

most challenging part turned out to be getting the

temperatures to match. When i finally poured the lye

water in to the oils - that was the best part -

especially when the mixture began to get creamy and I

witnessed the " trace " . It was so exciting. I am

cured of my fear of working with lye. All I have to

do is make sure I am doing this when no one is in the

house, and be really focused. I spread newspaper on

my countertops and moved every bit of cooking kitchen

utensil and objects/food.

It is a wonderful feeling. I am so glad I took the

plunge and went for it. I want to thank all of you

who responded to my e-mails and answered my concerns.

I felts prepared and somewhat knowledgeable - I just

had to get past my fear and sometimes just doing it

understanding what you know is all there is.

I am hooked. I must say again, the best part is

combining the oil and water and watching the creamy

part - knowing you are very close to making soap from

scratch.

Thank you, thank you, thank you.

Pat.

=====

The Stylish Collection - Handcrafted Soaps and more....

__________________________________________________

[Guest guest]

Welcome to the soap pot Pat!

Hugs!!

Beth

Deliah Fair

Re: Digest Number 971

[Guest guest]

pat i know how you feel . sadly i have not taken the time to make soap

lately. i went on many a splurge and have about 60+ bars 15 different scents

i need to build an addition on the house for all i wnat to do but for now

i sell to people who stop buy and allow my children to pick a bar for a bath

i am glad you have experienced the joy of soap making never forget this

first experience. no mater who's recipe you use it is like food it always

comes out different when you make it which happily makes it yours tamika

[Guest guest]

Hello. Please tell us what Young Living's essential oil Rain Drop Therapy is.

What are the ingredients (in case the herbal stores in my area doesnt

recognize the name). Any information will be appreciated. Thank you. Blue

[Guest guest]

" Can't We All Just Get Along " ;> You guys need to start using more

respectful language to each other. If we cannot even be nice to each

other,

how can we demand the respect we will need to help our children?

[Guest guest]

Frozen Grape lovers:

Someone mentioned freezing fruit, specifically grapes. Try champagne grapes,

they make a great frozen snack but I think they are only available for a short

time in the summer - at least here in New Jersey.

From " " < > on 30 Aug

2003:

>

>

[Guest guest]

Same for Bay Area of California. I don't know about Washington yet; I haven't seen any here.

r.

From: <newsletters@...>

Reply-

Date: Sun, 31 Aug 2003 06:29:21 -0700

" " < >

Subject: Re: [ ] Digest Number 971

Frozen Grape lovers:

Someone mentioned freezing fruit, specifically grapes. Try champagne grapes, they make a great frozen snack but I think they are only available for a short time in the summer - at least here in New Jersey.

From " " < > on 30 Aug 2003:

>

>

[Guest guest]

>Andy what are your sources my castro says end of 2004.Vertex is holding

>their product back due to finance settelment with other co. its all a

>greed issue to get these meds to us

No protease inhibitors are, or have ever been, in Phase IIIclinical

trials. These type of trials are necessary before a drug can be approved

and released for general use. Andy is quite correct when he says that

nothing new will arrive on scene for another 4-5 years.

You might want to ask your gastro where he is getting his info.

regards,

BobK

[Guest guest]

AS Andy indicated all trial with this drug (BLN2061)have been stopped. It

is very unlikely that this drug, in its current form, will ever make it to

market. The drug did show very good proof of concept but the toxicities

associated with its use, in the chimps, would preclude further trials. It

is a good starting point for protease inhibitor development for HCV

therapies.....but that is all that can be said about it at this time.

regards,

BobK

[Guest guest]

BILN 2061: HCV protease inhibitor

 

   Reported by Jules Levin

 

Two studies on this protease inhibitor were presented at AASLD in Boston

last week. Here are the results of BILN 2061 being studied in genotype 1

and non 1 genotypes. The study in genotype 1 was reported at last year?s

AASLD and the results were reported again this year. Future plans for

development of this drug seems uncertain but it is my understanding that

the developer, Boerhinger Ingleheim, has another HCV protease inhibitor

and an HCV polymerase inhibitor in earleier stages of development. Two

additional HCV protease inhibitors were reported on at AASLD. VX-950 is

being developed by Vertex Pharmaceuticals. In speaking with the company

they told me they are planning clinical development to begin in early

2004. Schering Plough is in phase I now with SCH-7, an HCV protease

inhibitor and is planning the next phase of studies for 2004.

 

SAFETY AND ANTIVIRAL EFFECT OF BILN 2061, A NOVEL HCV SERINE PROTEASE

INHIBITOR, AFTER ORAL TREATMENT OVER 2 DAYS IN PATIENTS WITH CHRONIC

HEPATITIS C, GENOTYPE 1, AND LIVER CIRRHOSIS.

 

Heiner Wedemeyer and colleagues from Boerhinger Inelheim reported on

this study in poster at AASLD. BILN 2061 is a potent and specific

inhibitor of the HCV serine protease in-vitro and in patients infected

with HCV genotype 1 (GT 1). In previous studies, no safety issues were

found in patients with minimal and advanced fibrosis who were treated

with BILN 2061 for 2 days. In a first exploratory trial, the effect of a

2-day oral treatment with BILN 2061 was investigated in patients with

liver cirrhosis who were infected with HCV GT 1.

 

In a randomized, double-blind group comparison, 10 patients with HCV GT

1(InnoLiPA) and liver cirrhosis (Child's A) were treated with 200 mg

BILN 2061 or placebo (randomized 8:2) given b.i.d. over 2 days in an

oral solution. Virus load (VL) was measured as HCV RNA by Cobas Amplicor

HCV Monitor v2.0.

 

Mean age of all 10 patients was 53 +/-9 years, 2 patients were female.

9/10 patients had been previously treated with anti-HCV therapy. All

patients completed the study and were followed up for 12 +/-2 days. VL

decreased by ?2 LOG10 units in 8/8 patients treated with 200mg BILN 2061

b.i.d. No VL decrease was observed in the 2 patients given placebo, one

being treatment-naïve. After end of treatment, VL returned to baseline

levels within 2-7 days.

 

ALT increased from 69 to 98 IU/mL in 1 BILN 2061-treated patient after 2

days of treatment, all other transaminase levels remained unchanged.

Analysis of adverse events, vital signs, routine laboratory and ECG did

not reveal relevant drug-induced changes. Tolerability was assessed by

the investigators as " good " in all 10 patients.

 

An oral dose of 200 mg BILN 2061 b.i.d. over 2 days demonstrated strong

antiviral activity against HCV GT 1 in patients with liver cirrhosis. No

safety issues were identified among the 8 patients treated with BILN

2061.

 

ANTIVIRAL EFFECT OF BILN 2061 AFTER ORAL TREATMENT OVER 2 DAYS IN

PATIENTS WITH CHRONIC HEPATITIS C, NON-GENOTYPE 1.

 

Markus Reiser and colleagues (Boerhinger Ingleheim) reported study

results. BILN 2061 is a potent and specific inhibitor of the HCV serine

protease in-vitro and in patients infected with genotype 1 (GT 1) as

recently reported. In a first exploratory trial, the effect of a 2-day

oral treatment with BILN 2061 was investigated in GT 2 and GT 3 patients

with minimal liver fibrosis.

 

In a randomized, double-blind group comparison, 10 male patients with

HCV other than GT 1 (InnoLiPA) and no or minimal liver fibrosis (Ishak

0-2) were administered 500 mg BILN 2061 or placebo in an oral solution

(randomized 8:2) b.i.d. over 2 days. Virus load (VL) was measured as HCV

RNA by Cobas Amplicor HCV Monitor v2.0.

 

Mean age of all 10 patients was 37 +/- 7 years. HCV genotypes were GT 2

(3 patients) and GT 3 (7 patients). 9/10 patients were naive for

anti-HCV therapy. All patients completed the study and were followed up

for 12 +/- 2 days. VL decreased by ?1 LOG10 unit in 4/8 patients treated

with 500mg BILN 2061 b.i.d., without detectable difference between GTs 2

and 3. A weak response was observed in 1 BILN 2061-treated patient,

whereas 3/8 BILN 2061-treated patients and 2/2 patients given placebo

experienced no response. The largest VL decrease was observed in the one

patient with GT 2 HCV that had been previously treated with anti-HCV

therapy. However HCV-RNA was still detectable. After end of treatment,

VL returned to baseline levels within 1-7 days.

 

No adverse events were reported. Liver function tests did not change

during treatment. Vital signs, routine laboratory and ECG did not show

relevant drug-induced changes. Tolerability was rated " good " by the

investigators in 9 patients and " satisfactory " in 1 BILN 2061-treated

patient.

 

BILN 2061, given p.o. over 2 days at 500 mg b.i.d., demonstrated

antiviral activity in 5/8 non-GT-1 in patients. In contrast to our

previous results in GT-1 patients, the antiviral activity was not

uniform and less pronounced. No safety issues were identified among the

8 patients exposed to BILN 2061.

[Guest guest]

Andy what are your sources my castro says end of 2004.Vertex is holding

their product back due to finance settelment with other co. its all a

greed issue to get these meds to us, how long you been on tx. and what

one ? if you dnt mind me asking hope your not 1a like me, oh can i tell

you some events about tx. I have a freind on HART 5 year progam,a

sargent in army her and husband got it threw vacine gun. Be nice to

satya were all in this together Peace out Rick

[Guest guest]

Presser from BI

note this line:There are currently no trials ongoing with BILN 2061

and decisions about future trials will be made after thorough

evaluation of toxicity findings in animal studies

Hepatitis C Drug Development at Boehringer Ingelheim

Ingelheim, Germany, 28 October 2003 - The journal Nature has

published an article describing a novel, small molecule anti-

hepatitis C virus (HCV) compound discovered by Boehringer Ingelheim

at its virology research center in Laval, Québec, Canada. The

compound, named BILN 2061, is an orally active inhibitor of the HCV

NS3 protease and the first member of this new drug class to be

tested in humans. The Nature paper describes the discovery and early

clinical trial results with BILN 2061 and demonstrates the promise

of this class of anti-HCV agents for the treatment of HCV disease.

Administration of BILN 2061 to a limited number of patients infected

with HCV for two days resulted in a marked reduction of the

hepatitis C virus plasma levels and established the first proof-of-

concept in man for an inhibitor acting by this mechanism. Routine

chronic safety testing of high, supra-therapeutic doses in animals

did, however, show relevant side effects which need further

analysis. Boehringer Ingelheim is currently studying the available

pre-clinical data in order to decide on their impact on the clinical

development of this substance. There are currently no trials ongoing

with BILN 2061 and decisions about future trials will be made after

thorough evaluation of toxicity findings in animal studies

Scientific results achieved so far are available to the medical

community.

General Information About Hepatitis C

Hepatitis C virus infection is a serious cause of chronic liver

disease with more than 170 million infected individuals worldwide.

Current interferon (IFN)-based therapies are suboptimal especially

in patients infected with HCV genotype 1 and are poorly tolerated,

highlighting the unmet medical need for novel therapeutics. The HCV-

encoded NS3 protease is an enzyme essential for viral replication

and has been considered an attractive target for therapeutic

intervention in infected patients.

Boehringer Ingelheim

The Boehringer Ingelheim Corporation is one of the world's 20

leading pharmaceutical companies. Headquartered in Ingelheim,

Germany, it operates globally with 156 affiliates in 44 countries

and a total of about 32,000 employees. Since it was founded in 1885,

the family-owned company has been committed to researching,

manufacturing and marketing novel products of high therapeutic value

for human and veterinary medicine.

In 2002, Boehringer Ingelheim posted net sales of 7.6 billion euro

while spending about one fifth of net sales in its largest business

segment Prescription Medicines on research and development.

Contact:

Sheila A. Burke

Associate Director, Communications & Public Relations

Boehringer Ingelheim Pharmaceuticals, Inc.

Ridgefield, CT 06877

203-798-4715

© 2003 Boehringer Ingelheim (Canada) Ltd./Ltée. All rights reserved.

Terms of use.

> BILN 2061: HCV protease inhibitor

>  

>    Reported by Jules Levin

>  

> Two studies on this protease inhibitor were presented at AASLD in

Boston

> last week. Here are the results of BILN 2061 being studied in

genotype 1

> and non 1 genotypes. The study in genotype 1 was reported at last

year?s

> AASLD and the results were reported again this year. Future plans

for

> development of this drug seems uncertain but it is my

understanding that

> the developer, Boerhinger Ingleheim, has another HCV protease

inhibitor

> and an HCV polymerase inhibitor in earleier stages of development.

Two

> additional HCV protease inhibitors were reported on at AASLD. VX-

950 is

> being developed by Vertex Pharmaceuticals. In speaking with the

company

> they told me they are planning clinical development to begin in

early

> 2004. Schering Plough is in phase I now with SCH-7, an HCV protease

> inhibitor and is planning the next phase of studies for 2004.

>  

> SAFETY AND ANTIVIRAL EFFECT OF BILN 2061, A NOVEL HCV SERINE

PROTEASE

> INHIBITOR, AFTER ORAL TREATMENT OVER 2 DAYS IN PATIENTS WITH

CHRONIC

> HEPATITIS C, GENOTYPE 1, AND LIVER CIRRHOSIS.

>  

> Heiner Wedemeyer and colleagues from Boerhinger Inelheim reported

on

> this study in poster at AASLD. BILN 2061 is a potent and specific

> inhibitor of the HCV serine protease in-vitro and in patients

infected

> with HCV genotype 1 (GT 1). In previous studies, no safety issues

were

> found in patients with minimal and advanced fibrosis who were

treated

> with BILN 2061 for 2 days. In a first exploratory trial, the

effect of a

> 2-day oral treatment with BILN 2061 was investigated in patients

with

> liver cirrhosis who were infected with HCV GT 1.

>  

> In a randomized, double-blind group comparison, 10 patients with

HCV GT

> 1(InnoLiPA) and liver cirrhosis (Child's A) were treated with 200

mg

> BILN 2061 or placebo (randomized 8:2) given b.i.d. over 2 days in

an

> oral solution. Virus load (VL) was measured as HCV RNA by Cobas

Amplicor

> HCV Monitor v2.0.

>  

> Mean age of all 10 patients was 53 +/-9 years, 2 patients were

female.

> 9/10 patients had been previously treated with anti-HCV therapy.

All

> patients completed the study and were followed up for 12 +/-2

days. VL

> decreased by ?2 LOG10 units in 8/8 patients treated with 200mg

BILN 2061

> b.i.d. No VL decrease was observed in the 2 patients given

placebo, one

> being treatment-naïve. After end of treatment, VL returned to

baseline

> levels within 2-7 days.

>  

> ALT increased from 69 to 98 IU/mL in 1 BILN 2061-treated patient

after 2

> days of treatment, all other transaminase levels remained

unchanged.

> Analysis of adverse events, vital signs, routine laboratory and

ECG did

> not reveal relevant drug-induced changes. Tolerability was

assessed by

> the investigators as " good " in all 10 patients.

>  

> An oral dose of 200 mg BILN 2061 b.i.d. over 2 days demonstrated

strong

> antiviral activity against HCV GT 1 in patients with liver

cirrhosis. No

> safety issues were identified among the 8 patients treated with

BILN

> 2061.

>  

> ANTIVIRAL EFFECT OF BILN 2061 AFTER ORAL TREATMENT OVER 2 DAYS IN

> PATIENTS WITH CHRONIC HEPATITIS C, NON-GENOTYPE 1.

>  

> Markus Reiser and colleagues (Boerhinger Ingleheim) reported study

> results. BILN 2061 is a potent and specific inhibitor of the HCV

serine

> protease in-vitro and in patients infected with genotype 1 (GT 1)

as

> recently reported. In a first exploratory trial, the effect of a 2-

day

> oral treatment with BILN 2061 was investigated in GT 2 and GT 3

patients

> with minimal liver fibrosis.

>  

> In a randomized, double-blind group comparison, 10 male patients

with

> HCV other than GT 1 (InnoLiPA) and no or minimal liver fibrosis

(Ishak

> 0-2) were administered 500 mg BILN 2061 or placebo in an oral

solution

> (randomized 8:2) b.i.d. over 2 days. Virus load (VL) was measured

as HCV

> RNA by Cobas Amplicor HCV Monitor v2.0.

>  

> Mean age of all 10 patients was 37 +/- 7 years. HCV genotypes were

GT 2

> (3 patients) and GT 3 (7 patients). 9/10 patients were naive for

> anti-HCV therapy. All patients completed the study and were

followed up

> for 12 +/- 2 days. VL decreased by ?1 LOG10 unit in 4/8 patients

treated

> with 500mg BILN 2061 b.i.d., without detectable difference between

GTs 2

> and 3. A weak response was observed in 1 BILN 2061-treated patient,

> whereas 3/8 BILN 2061-treated patients and 2/2 patients given

placebo

> experienced no response. The largest VL decrease was observed in

the one

> patient with GT 2 HCV that had been previously treated with anti-

HCV

> therapy. However HCV-RNA was still detectable. After end of

treatment,

> VL returned to baseline levels within 1-7 days.

>  

> No adverse events were reported. Liver function tests did not

change

> during treatment. Vital signs, routine laboratory and ECG did not

show

> relevant drug-induced changes. Tolerability was rated " good " by the

> investigators in 9 patients and " satisfactory " in 1 BILN 2061-

treated

> patient.

>  

> BILN 2061, given p.o. over 2 days at 500 mg b.i.d., demonstrated

> antiviral activity in 5/8 non-GT-1 in patients. In contrast to our

> previous results in GT-1 patients, the antiviral activity was not

> uniform and less pronounced. No safety issues were identified

among the

> 8 patients exposed to BILN 2061.

[Guest guest]

hey Biggrick, you skinslapper you! Taking on quite a force aren't you? sounds like you're doing well and are full of piss and vinegar! blessings, Satya

Re: [ ] Digest Number 971

Andy what are your sources my castro says end of 2004.Vertex is holdingtheir product back due to finance settelment with other co. its all agreed issue to get these meds to us, how long you been on tx. and whatone ? if you dnt mind me asking hope your not 1a like me, oh can i tellyou some events about tx. I have a freind on HART 5 year progam,asargent in army her and husband got it threw vacine gun. Be nice tosatya were all in this together Peace out Rick

[Guest guest]

It's on the calendar for Monday Dec. 6. It says at the Bel/Red Red Robin but

we had talked about moving it this month. So you might want to check back &

see if has updated the location. If not we'll see you at Red Robin. A

reminder should go out soon as well.

Hope to see you there!

Gen

280/208/160

Message: 3

Date: Thu, 2 Dec 2004 09:20:57 -0800

From: " Cyndie McGrayne " <cyndie.mcgrayne@...>

Subject: RE: Digest Number 970

I have not seen anything about the Kirkland Soup Night, I am anxious to

meet fellow bandsters, can someone let me know the details of when and

where?

Cyndie D. McGrayne

cyndie.mcgrayne@...

Dr. Alpoverich

11/01/2004

255/236.5/139

[Guest guest]

Hey Gen,

I've been a stranger, but what time is the Red Robin meetup?

SylviaF

_____

From: Curry Groups [mailto:groups@...]

Sent: Thursday, December 02, 2004 11:57 AM

Subject: RE: Digest Number 971

It's on the calendar for Monday Dec. 6. It says at the Bel/Red Red Robin but

we had talked about moving it this month. So you might want to check back &

see if has updated the location. If not we'll see you at Red Robin. A

reminder should go out soon as well.

Hope to see you there!

Gen

280/208/160

Message: 3

Date: Thu, 2 Dec 2004 09:20:57 -0800

From: " Cyndie McGrayne " <cyndie.mcgrayne@...>

Subject: RE: Digest Number 970

I have not seen anything about the Kirkland Soup Night, I am anxious to

meet fellow bandsters, can someone let me know the details of when and

where?

Cyndie D. McGrayne

cyndie.mcgrayne@...

Dr. Alpoverich

11/01/2004

255/236.5/139

[Guest guest]

Just for the record i am on 15mg of Lexapro...I seem to go back and forth from

prozac to lexapro.....every6 months or so one then the other.....I hate the med

change....if I get the flu or sick then it seems the one I am taking stops

working so I have to change. When I hear some have been on one for years at a

time I wish I was like that that is if I have to take one. I have heard some

have been on zolof for years. I can't seem to achieve that. So I go back and

forth. The sides to Lexapro are so much less than the others for me....it is

like day and night. My doc long time ago when he put me on it told me the sides

were less and he was right. This time don't seem to be responding like I use

too...I am having chronic pain and prayerfully getting a new disc in my back. I

am just depressed and can't seem to shake it this time. I have been on it for

about 5 weeks. Not sure what I am going to do at this point. Just got medicade

with my medicare and have to change all new doctors so I can

have this surgery and I don't seem to feel as confident finding new doctors and

being in a new town so I think I am contributing it to that. It is Sunday and I

think I am going to the doctor today. That is haw I am feeling....O me! Not sure

if this helped anyone....my diagnoses is Gad with panic and major depression.

Debbie

There are 4 messages in this issue.

Topics in this digest:

1. Itching

From: " bnelkin "

2. question about starting lexapro

From: " ilola1234 "

3. Re: question about starting lexapro

From: " Bipolar "

4. Re: question about starting lexapro

From: dyrtylurker@...

________________________________________________________________________

________________________________________________________________________

Message: 1

Date: Sat, 14 May 2005 23:23:24 -0000

From: " bnelkin "

Subject: Itching

I'm a new subscriber to this web site, and I'm interested in hearing if anyone

has a similar problem.

I was diagnosed withTourette's Syndrome many years ago and only recently

have been told by my neurologist (who is world- renown) that I also have

OCD. I was given samples of Lexapro months ago, but took only one because

ot the side effects. I have had a problem with itching for any decades and

have seen many dermatologists and tried all sorts of treatments with no

satisfactory results. My current dermatologist now agrees that the itching is

caused by the OCD and that I should try Lexapro. I'm really hesitant to begin

taking this drug, but I feel that I must get the itching under control.

Any input from anyone on this matter will be greatly appreciated.

B

________________________________________________________________________

________________________________________________________________________

Message: 2

Date: Sun, 15 May 2005 01:29:52 -0000

From: " ilola1234 "

Subject: question about starting lexapro

Hi all, i'm emily. My doctor just put me on lex (5mg) for

depression and anxiety. I've been on it for a little more

than one week. I've been on other antidepressants (zoloft,

paxil, welbutrin & effexor) in the past but could not

tolerate the side effects (mostly the inability to sleep). But

I've been having a hard time lately so decided to try again.

Anyway this is the first one that had more than physical side effects

for me. At first it made me more depressed and more anxious.

These effects have mostly subsided but I still feel like a zombie

sometimes and not so sharp. I'm wondering if its going to effect my

ability to think properly I can't be on it due to my job. I'm

wondering do I stick it out for a couple more weeks? Will

the clouded head side effect go away as well? Any experiences

with this would be appreciated.

________________________________________________________________________

________________________________________________________________________

Message: 3

Date: Sat, 14 May 2005 20:33:40 -0500 (Central Daylight Time)

From: " Bipolar "

Subject: Re: question about starting lexapro

I am on 20mg Lexapro and I notice that I have less of an appetite, more

energy and am more anxious than before....anyone else had the same

reactions???? I have been on it about 3 weeks.......

-- question about starting lexapro

Hi all, i'm emily. My doctor just put me on lex (5mg) for

depression and anxiety. I've been on it for a little more

than one week. I've been on other antidepressants (zoloft,

paxil, welbutrin & effexor) in the past but could not

tolerate the side effects (mostly the inability to sleep). But

I've been having a hard time lately so decided to try again.

Anyway this is the first one that had more than physical side effects

for me. At first it made me more depressed and more anxious.

These effects have mostly subsided but I still feel like a zombie

sometimes and not so sharp. I'm wondering if its going to effect my

ability to think properly I can't be on it due to my job. I'm

wondering do I stick it out for a couple more weeks? Will

the clouded head side effect go away as well? Any experiences

with this would be appreciated.

[Guest guest]

I will check it out.

-----------------------

Sev,

Thanks. so that idea is now moot.

--- Coconut Oil wrote:

> There are 2 messages in this issue.

>

> Topics in this digest:

>

> 1. Pixba palm

> From: Wilkins

> <montemomma2002@...>

> 2. Re: Digest Number 966

> From: Severino Magat

> <sev_magat@...>

>

>

>

________________________________________________________________________

>

________________________________________________________________________

>

> Message: 1

> Date: Mon, 10 Apr 2006 05:47:23 -0700 (PDT)

> From: Wilkins <montemomma2002@...>

> Subject: Pixba palm

>

>

>

> Hi ,

>

> This link will take you to a page with a bunch of

> tropical plants and their scientific names. Scroll

> down to the palms and you will find it. I cant find

> a page with a picture of it , but it is a beautiful

> bright redish orange in color.If you read Spanish

> there are a few links when I googled this that

> describe it in Spanish.

> IN NC

>

>

http://www.faculty.ucr.edu/~legneref/botany/ethnic6.htm

>

>

> Wilkins

> http//:www.juiceplus.com/+lw55887

> The Children's Research Foundation Children 6-15

> FREE for 3 years

>

>

> ---------------------------------

> Messenger with Voice. Make PC-to-Phone Calls

> to the US (and 30+ countries) for 2¢/min or less.

>

> [Non-text portions of this message have been

> removed]

>

>

>

>

________________________________________________________________________

>

________________________________________________________________________

>

> Message: 2

> Date: Tue, 11 Apr 2006 03:39:41 -0700 (PDT)

> From: Severino Magat <sev_magat@...>

> Subject: Re: Digest Number 966

>

> Dear ,

>

> Niece to hear from you from another continent

> across the pacific !

>

> Coconut husks from matured nuts contains 43%

> lignin and coir dust (or cocopeat) higher

> (54.8%),While, the less resistant cellulose and

> hemicellulose with 23.9 and 8.5%, respectively.

> Lignin is a complex aromatic compound, chemistry of

> which not fully understood, considered to be a

> polymer of phenyl propane units. It is deposited in

> cell walls, xylem vessels (water conducting

> tissues), making coir fibers and coir dust strong

> and rigid. I think it's not practical to isolate

> enzyme-producing fungus and /or bacteria from the

> lignin-rich coconut husks.

>

> Perhaps I should end here. Cheers,

>

> Sev Magat

>

> melly banagale <@...> wrote:

> Hi Sev

>

> Replying to you from Austin, Texas. You say the

> husk

> is lignin rich to protect from biological

> factors....Can the lignin from its husk not be

> isolated to be used in the production of the vco?

> Has

> the PCA done research on its effects, both positive

> and negative? Is the lignin the wax like cover of

> the

> husk? Maybe we can scrape and melt it then put a

> few

> drops in the oil if the research and testing results

> are good and does not pose any health hazard.

>

> Thanks

>

>

>

> > Message: 3

> > Date: Wed, 5 Apr 2006 21:40:28 -0700 (PDT)

> > From: Severino Magat <sev_magat@...>

> > Subject: Re: Digest Number 965

> >

> > , Hi !

> >

> > You're quite right, dehusked nuts of coconut

> > fruits have hairs if not manually removed with a

> > scrapping tool as a sharp knife.

> >

> > Allow me to provide further clarification on

> this

> > matter. If we visualize a split fruit, we could

> see

> > the outer skin (exocarp), the husk (mesocarp), the

> > shell (exocarp), the seed-coat (testa or paring),

> > the meat (endosperm or kernel) and the coconut

> water

> > ( also considered the liquid endosperm or the

> > juice). The husk which protects the shell, meat

> and

> > water) is composed of long, medium and dust

> fibers,

> > with the mixed long and medium size natural fibers

> (

> > lignin-rich, highly resistant to biological

> > decomposition). Usually after separating the

> coconut

> > fruit fibers (husk) from the shell, many fibers

> > still remain attached to it. This normal

> condition,

> > seemingly show us that the outer portion of the

> > shell is " hairy " .

> >

> > Cheers,

> >

> > Sev Magat

> >

> > melly banagale <@...> wrote:

> > I think all coconuts have hairy shells. The

> > reason

> > they are not hairy is they have been scraped off

> > before putting them in the shelves. The young

> ones

> > have less hair though.

> >

> >

> >

> >

> >

> > __________________________________________________

> >